Biomarker profiles as descriptors of left ventricular remodeling after acute myocardial infarction

Coronary Artery Disease

Volumn 22, Issue 5, 2011, Pages 311-316

  Lam, Phillip H ^a   Anderson III, Phillip R ^a   Ahmed, Bina ^a   Sobel, Burton E ^a   Vanburen, Peter ^a   Schneider, David J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

cytokine; inflammation; myocardial infarction; remodeling

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHEMOKINE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EOTAXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PLATELET DERIVED GROWTH FACTOR AA; RANTES; THIENOPYRIDINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HELPER CELL; HUMAN; HUMORAL IMMUNITY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TH2 CELL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; TH1-TH2 BALANCE; VENTRICULAR REMODELING;

EID: 79960699168     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328346b88d     Document Type: Article

References (29)

1. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998; 128:127-137. (Pubitemid 28053135)
2. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999; 99:2079-2084. (Pubitemid 29196789)
3. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, Harris TB. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 2001; 103:947-953. (Pubitemid 32183799)
4. Koenig W. Inflammation and coronary heart disease: an overview. Cardiol Rev 2001; 9:31-35. (Pubitemid 32060596)
5. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973-979. (Pubitemid 27152782)
6. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-843. (Pubitemid 30165206)
7. Pfeffer MA, Greaves SC, Arnold JM, Glynn RJ, LaMotte FS, Lee RT, et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction: the healing and early after load reducing therapy trial. Circulation 1997; 95:2643-2651. (Pubitemid 27255493)
8. Devos T, Shengqiao L, Gysemans C, Yan Y, Damme BV, Nelson-Holte M, et al. Late CD8+ T cell-dependent xenoantibody production in innate tolerant nude rats after hamster islet grafting but not after hamster heart grafting. Transplantation 2008; 85:1489-1495.
9. Piccinni MP. T cell tolerance towards the fetal allograft. J Reprod Immunol 2010; 85:71-75.
10. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 353:1685-1695.
11. Correale M, Brunetti ND, De Gennaro L, Di Biase M. Acute phase proteins in atherosclerosis (acute coronary syndrome). Cardiovasc Hematol Agents Med Chem 2008; 6:272-277.
12. Tan J, Hua Q, Gao J, Fan ZX. Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction. Clin Cardiol 2008; 31:413-418.
13. Hilfiker-Kleiner D, Shukla P, Klein G, Schaefer A, Stapel B, Hoch M, et al. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction. Circulation 2010; 122:145-155.
14. Sobue S, Nomura T, Ishikawa T, Ito S, Saso K, Ohara H, et al. Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection. J Gastroenterol 2001; 36:544-551. (Pubitemid 32791841)
15. Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR, Blotta MH. Increased Th1 activity in patients with coronary artery disease. Cytokine 2004; 26:131-137. (Pubitemid 38596923)
16. Szodoray P, Timar O, Veres K, Der H, Szomjak E, Lakos G, et al. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines: immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol 2006; 64:336-344. (Pubitemid 44215124)
17. Mossman TR, Moore KW. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 1991; 12:A49-A53. (Pubitemid 121002459)
18. Takeshita S, Gage JR, Kishimoto T, Vredevoe DL, Martínez-Maza O. Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol 1996; 156:2591-2598. (Pubitemid 26091589)
19. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-1220.
20. Frangogiannis NG, Mendoza LH, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol 2000; 165:2798-2808. (Pubitemid 30660731)
21. Rea IM, McNerlan SE, Alexander HD. Total serum IL-12 and IL-12p40, but not IL-12p70, are increased in the serum of older subjects; relationship to CD3( + )and NK subsets. Cytokine 2000; 12:156-159. (Pubitemid 30449869)
22. Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 2009; 8:40-52.
23. Apostolakis S, Papadakis EG, Krambovitis E, Spandidos DA. Chemokines in vascular pathology (Review). Int J Mol Med 2006; 17:691-701.
24. Frangogiannis NG, Entman ML. Chemokines in myocardial ischemia. Trends Cardiovasc Med 2005; 15:163-169. (Pubitemid 41297626)
25. Hayashidani S, Tsutsui H, Shiomi T, Ikeuchi M, Matsusaka H, Suematsu N, et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2003; 108:2134-2140. (Pubitemid 37337591)
26. Frangogiannis NG. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res 2004; 53:585-595. (Pubitemid 40385316)
27. Naito K, Anzai T, Sugano Y, Maekawa Y, Kohno T, Yoshikawa T, et al. Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction. J Immunol 2008; 181:5691-5701.
28. Virag JA, Rolle ML, Reece J, Hardouin S, Feigl EO, Murry CE. Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function. Am J Pathol 2007; 171:1431-1440. (Pubitemid 350158305)
29. Tanaka N, Masamura K, Yoshida M, Kato M, Kawai Y, Miyamori I. A role of heparin-binding epidermal growth factor-like growth factor in cardiac remodeling after myocardial infarction. Biochem Biophys Res Commun 2002; 297:375-381. (Pubitemid 35216181)